文献速递慢性肾脏病遗传性与小管间质肾病血液净化与透析

巴西人群APOL1相关肾病研究

APOL1-Associated Kidney Disease in Brazil.
PubMed 文献 · Kidney Int Rep · 2019-03-20

该病例对照研究在巴西非洲裔血液透析患者中检测APOL1基因型,发现两个风险等位基因携带者终末期肾病风险约为对照的10倍,且透析起始年龄提前12年;风险等位基因频率低于美国报告。

要点

  • 巴西非洲裔透析患者中两个APOL1风险等位基因频率为9.4%,低于美国报告。
  • 携带两个风险等位基因者终末期肾病风险显著升高(OR 10.95)。
  • 两个风险等位基因携带者透析起始年龄较零风险等位基因者早12年。

核心结论

  • 巴西非洲裔透析患者中APOL1风险等位基因频率低于美国,但两个风险等位基因仍与终末期肾病风险约10倍升高相关。
  • 两个风险等位基因携带者透析起始年龄明显更早,提示疾病表型更具侵袭性。

研究设计与样本

  • 病例对照研究,纳入106例巴西非洲裔血液透析患者与106名健康一级亲属对照进行APOL1基因型检测。
  • 采用线性混合模型分析风险等位基因与终末期肾病的关联,并校正亲缘关系和其他混杂因素。
  • 扩展调查分析274例血液透析患者的透析起始年龄与APOL1变异。

主要发现

  • 两个APOL1风险等位基因在终末期肾病患者中频率为9.4%,对照组为0.9%(OR 10.95,SE=1.49,P=0.0017)。
  • 携带两个风险等位基因者透析起始年龄比零风险等位基因者早12年。

临床怎么用

  • 对巴西非洲裔人群可考虑APOL1基因检测以评估终末期肾病风险。
  • 两个风险等位基因携带者需更密切监测肾功能,因其透析起始年龄可能显著提前。

局限性

  • 病例对照设计样本量有限(106对),扩展调查为274例。
  • 研究仅纳入巴西非洲裔人群,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Coding variants in apolipoprotein L-1 (APOL1) are associated with an increased risk of end-stage kidney disease (ESRD) in African American individuals under a recessive model of inheritance. The effect of the APOL1 risk alleles on kidney disease has been observed in studies in African American and African populations. Despite the 130 million individuals of recent African ancestry in South America, the impact of APOL1 has not been explored. METHODS: In this case-control study, we tested APOL1 genotype in 106 Brazilian HD (hemodialysis) patients with African ancestry and compared risk allele frequency with 106 healthy first-degree relatives. The association of risk alleles and ESRD was calculated with a linear mixed model and was adjusted for relatedness and additional confounders. In a broader survey, the age of dialysis initiation and APOL1 variants were analyzed in 274 HD patients. RESULTS: Two APOL1 risk alleles were 10 times more common in patients with ESRD than in controls (9.4% vs. 0.9%; odds ratio [OR]: 10.95, SE = 1.49, P = 0.0017). Carriers of 2 risk alleles initiated dialysis 12 years earlier than patients with zero risk alleles. CONCLUSION: The APOL1 risk variants were less frequent in dialysis patients of African ancestry in Brazil than in the United States. Nonetheless, carriers of 2 risk variants had 10-fold higher odds of ESRD. Age of dialysis initiation was markedly lower in 2-risk allele carriers, suggesting a more aggressive disease phenotype. The Brazilian population represents an opportunity to identify different sets of genetic modifiers or environmental triggers that might be present in more extensively studied populations.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Riella C, Siemens TA, Wang M, et al. APOL1-Associated Kidney Disease in Brazil. Kidney Int Rep. 2019. PMID: 31317114. doi:10.1016/j.ekir.2019.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。